A clinical trial to compare the effects of single injection versus a combination of two injections in pain relief for patients with progressive cervical cancer
Phase 2
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2022/11/046992
- Lead Sponsor
- DrPoornaMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. All onco-patients with progressive cervical cancers who have recieved first line of treatment with FIGO stage <4
2.Pain in pelvi-perineal region with pain score >4
3.Patients with progressive cervical cancer receiving chemotherapy who have completed the chemotherapy for atleast 3 weeks before the interventional injection.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 50% pain relief after procedure both immediate and delayedTimepoint: Pain score - <br/ ><br>1. Before procedure <br/ ><br>2.Immediately after procedure <br/ ><br>3.2 hours, 12hours, 24hours, 1week, 2 weeks, 1months and 3 months after procedure.
- Secondary Outcome Measures
Name Time Method 1. the impact on Morphine consumption (or MEDD) 2. The quality of life(QOL)Timepoint: 1. Pre-procedure <br/ ><br>2. 1 week, 1 month, 3 months after the procedure.